In a mouse AML model with MRD positivity, persisting leukemic blasts became more resistant over time to cytotoxic T-cell-mediated killing, concomitantly associated with increased PD-L1 and CTLA-4 expression. The gene discussed is CTLA4; the disease is acute myeloid leukemia.